Curiox Biosystems Closes $15M Series C Funding Round


Curiox Biosystems, Inc., a Woburn, Mass.-based leader in biological sample preparation automation, closed a $15m Series C financing round.

Luha Private Equity led the deal, joined by other existing investors KB Investment Co., Ltd and Quad Investment Management Corp., all major players in the Korean venture capital market.

Funds from the investment will enable the company to expand its global operations and advance new solutions to ensure accurate analysis of cells in their native state.

Led by CEO Namyong Kim, Ph.D., Curiox commercializes Laminar Wash™ technology, a methodology that transforms manual cell preparation into an efficient and standardized workflow, enabling next-generation life science research and product development.

At the heart of the technology are Laminar Wash systems, which combine novel “wall-less” plate design with automated fluidics that reproducibly prepares cells for high-content analysis methods, such as single-cell sequencing ‘omics and flow cytometry. Major biopharmaceutical multinationals, biotech companies, as well as prominent academic labs are quickly adopting Laminar Wash technology to replace conventional centrifugation-based cell washing methods. Integrating Laminar Wash systems in their workflows enables teams to scale high-throughput analysis through automation, improve workflows and productivity, consume fewer reagents and sample volumes, and retain precious and rare cells for analysis that otherwise would be lost by harsh pelleting and stress.